Zyban (Wellbutrin)a no-go, hmmm....

[Guest guest]

'magine that. Looks like the body count is speaking for itself when

it comes to Zyban, aka, the antidepressant Wellbutrin. Wonder whose choice

the exclusion was - GSK or HealthMedia...hmmmm....

http://www.ananova.com/business/story/sm_502880.html

Home Your News News Entertainment Sport Business Video Reports

Weather Going Out TV Guide Site Directory News Search About Ananova

Colt TelecomMarks SpencerPowerGen

BREAKING NEWS:

The FTSE 100 Index closed 49.2 points ahead at 5073.3 with a rally among telecom stocks.

Full story

Business

Latest headlines

Business news A-Z

News by sector

Technology news

Economy

Share prices

Market reports

Business quirkies

Currency news

Personal finance

Popular UK shares

Popular world shares

Tourist rates

News by email & WAP

Ananova on WAP

Get involved

Your News

News

Entertainment

Sport

Feedback

Corrections

Site Search

Ananova :

GlaxoKline, US' HealthMedia form venture to promote anti-smoking products

GlaxoKline PLC said it signed a deal with specialist US Group, HealthMedia to promote products through the development of personalised programmes to help smokers give up.

The programmes will be distributed primarily through the internet.

The deal with HealthMedia covers GSK's nicotine-based products, such as Nicorette chewing gum and NicoDerm patches in the UK and Nicabate patches in Australia and New Zealand, sold as NiQuitin elsewhere, designed to help people quit.

The deal with HealthMedia, initially for development in Europe and Japan, will allow smokers who want to kick the habit, to sign up free of charge for a personalised programme, which will be based on their needs and medical history, as long as they have bought one of GSK's products.

The agreement does not include the controversial non nicotine-based Zyban. Last week, the Medicines Control Agency last week revealed that 57 people died in the UK after taking the Zyban anti smoking treatment, since its launch in July 2000.

© AFX News

Story filed: 18:31 Wednesday 23rd January 2002ADD THESE SUBJECTS TO YOUR NEWS: Find out how

GlaxoKline

Alerts by sector - Pharmaceuticals

SHARE THIS NEWS:Email this story to a friend RELATED STORIES:

GlaxoKline licenses in pre-clinical drugs from Bayer

09:44 Monday 18th February 2002

GlaxoKline, Roche in postmenopausal osteoporosis treatment tie-up

07:34 Friday 7th December 2001

More related stories

CHECK FOR MORE ON:

Joint ventures

UK

Pharmaceuticals

Glaxosmithkline PLC

AFX business wire

Business

Home - Your News - News - Entertainment - Sport - Business - Weather - Video Reports - Going Out - TV Guide - Site Directory - News Search - About Ananova - Contact Ananova

Copyright © 2002 Ananova Ltd Terms and conditions of use - Privacy policy - Corrections